Connect
MJA
MJA

The newer contraceptive pills and venous thromboembolism risk

Therese M Foran
Med J Aust 2014; 200 (7): 376-377. || doi: 10.5694/mja14.00274

Despite 20 years of controversy, the definitive answer as to whether newer contraceptive pills further increase venous thromboembolism risk remains elusive

The 19th century German physician Rudolf Virchow described the mechanism of venous thromboembolism (VTE) in terms of interactions between haemodynamics, vein wall disruption and hypercoagulability. An understanding of this interplay is particularly important in a women’s health context since changes in the hormonal milieu, such as those seen in pregnancy and the use of exogenous oestrogen therapy, may act in concert to further increase VTE risk.

  • Therese M Foran

  • School of Women’s and Children’s Health, University of New South Wales, Sydney, NSW.

Correspondence: t.foran@unsw.edu.au

Competing interests:

I have been a member of a number of advisory committees for MSD and Bayer — both of which market COCPs in Australia. I have developed educational material for educational sessions sponsored by MSD and Bayer, and accepted an honorarium on these occasions. I have accepted sponsorship from a number of pharmaceutical companies to enable me to attend and present at conferences relevant to my area of expertise. I am a sub-investigator at the Women’s Health and Research Institute of Australia (attached to the Royal Hospital for Women, Sydney) which conducts pharma-sponsored clinical trials.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.